<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CEFPROZIL</span><br/>(cef'pro-zil)<br/><span class="topboxtradename">Cefzil<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antibiotic</span>; <span class="classification">second-generation cephalosporin</span><br/><b>Prototype: </b>Cefonicid sodium<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>250 mg, 500 mg tablets; 125 mg/5 mL, 250 mg/5 mL suspension</p>
<h1><a name="action">Actions</a></h1>
<p>Semisynthetic, second-generation cephalosporin antibiotic with drug structure characterized by a beta-lactam ring; generally
         resistant to hydrolysis by beta-lactamases. Preferentially binds to proteins in cell walls of susceptible organisms, thus
         killing the bacteria. Also active against organisms susceptible to first generation cephalosporin.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Active against <i>Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis</i>, and <i>Staphylococcus aureus</i>. Effectively treats upper and lower respiratory tract infections, otitis media and sinusitis, and skin infections, eliminating
         or reducing infection.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Upper and lower respiratory tract infections, otitis media, skin infections.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to cephalosporin and related antibiotics; severely impaired renal or hepatic function; pregnancy (category
         B).
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Lactation; patients with delayed reaction to penicillin or other drugs; GI disease, especially colitis.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Mild to Moderate Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 250500 mg q1224h for 1014 d<br/><span class="rdage">Child <i>&gt;6 mo</i>
                  				:</span> <span class="rdroute">PO</span> 15 mg/kg q12h<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Drug may be given without regard to meals.</li>
<li>Consult physician for patients with impaired renal function. Dose is reduced by 50% when creatinine clearance is 030
            mL/min.
         </li>
<li>Administer after hemodialysis since drug is partially removed by dialysis.</li>
<li>After reconstitution, oral suspension is refrigerated. Discard unused portion after 14 days.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Body as a Whole:</span> Hypersensitivity reactions, superinfections. <span class="typehead">GI:</span> Nausea, vomiting, diarrhea, abdominal pain. <span class="typehead">Hematologic:</span> Eosinophilia. <span class="typehead">CNS:</span> Headache. <span class="typehead">Skin:</span> Rash, diaper rash. <span class="typehead">Urogenital:</span> Genital pruritus, vaginal candidiasis. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>May cause a positive <span class="alt">direct Coombs' test;</span> false-negative results in the ferricyanide assay for <span class="alt">blood glucose;</span> false-positive reactions for <span class="alt">urine glucose</span> with <span class="alt">copper reduction tests</span> such as <span class="alt">Benedict's</span> or <span class="alt">Fehling's solution</span> or <span class="alt">Clinitest tablets;</span> increased <span class="alt">partial thromboplastin time,</span> indicating thrombocytosis, eosinophilia; minor elevations in <span class="alt">serum alanine aminotransferase (ALT),</span>
<span class="alt">aspartate aminotransferase (AST),</span> and <span class="alt">bilirubin.</span>
</p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Probenecid</b> prolongs the elimination of cefprozil. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Peak:</span> 12 h. <span class="typehead">Distribution:</span> Distributes into blister fluid at 50% of the serum level. <span class="typehead">Elimination:</span> Primarily excreted by the kidneys. <span class="typehead">Half-Life:</span> 12 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Determine previous hypersensitivity to cephalosporins or penicillins before treatment.</li>
<li>Withhold drug and notify physician if hypersensitivity occurs (e.g., rash, urticaria).</li>
<li>Lab tests: Perform culture and sensitivity tests before and periodically during therapy. Therapy may be initiated while results
            are pending.
         </li>
<li>Monitor for and report diarrhea, as pseudomembranous colitis is a potential adverse effect.</li>
<li>Monitor for and report signs of superinfection (see Appendix F).</li>
<li>When given concurrently with other cephalosporins or aminoglycosides, monitor for signs of nephrotoxicity.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Complete the prescribed course of therapy, even if symptom free.</li>
<li>Report rash or other signs of hypersensitivity immediately.</li>
<li>Report signs of superinfection (see Appendix F).</li>
<li>Report loose stools and diarrhea even after completion of drug therapy.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>